Cite

HARVARD Citation

    Dunleavy, K. et al. (n.d.). RISK‐ADAPTED THERAPY IN ADULTS WITH BURKITT LYMPHOMA: UPDATED RESULTS OF a MULTICENTER PROSPECTIVE PHASE II STUDY OF DA‐EPOCH‐R. Hematological oncology. pp. 133-134. [Online]. 
  
Back to record